12109297 · Active · incorporated 7 years, 1 month ago · Oxford
Biotech Deep Tech Drug Discovery Healthcare Platform Series B+
Nucleome Therapeutics decodes the non-coding human genome to discover new ways to treat diseases.
Nucleome is a private limited company registered at Companies House under number 12109297, incorporated on 17 July 2019, with a registered office in Oxford. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 87 filings for this company, including 3 funding rounds. Its most recent round closed in September 2025, raising £18.8m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Sep 2025 | £18.8m | £0.01 |
| Round 2 | Nov 2022 | £18.8m | £1.04 |
| Round 1 | Aug 2019 | £5.2m | £1.00 |
Showing the 10 most recent of 87 filings.
See the complete cap table with every shareholder, founder tags, dilution across 29 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.